Patents by Inventor Jonathan S WEISSMAN

Jonathan S WEISSMAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250145726
    Abstract: Provided herein are compositions and methods of modulating myeloid cell-mediated killing of cancer cells and modulating the activity of myeloid cell immune checkpoint inhibitors. Also provided herein are methods of screening for modulators of myeloid cell-mediated killing of cancer cells and modulators of myeloid cell immune checkpoint inhibitors.
    Type: Application
    Filed: February 10, 2023
    Publication date: May 8, 2025
    Inventors: Kipp Weiskopf, Jonathan S. Weissman, Dian Yang
  • Publication number: 20230042624
    Abstract: Methods, compositions, and kits are provided for CRISPR/Cas mediated transcriptional modulation.
    Type: Application
    Filed: January 24, 2022
    Publication date: February 9, 2023
    Inventors: Luke A. Gilbert, Max Horlbeck, Martin Kampmann, Lei S. Qi, Jonathan S. Weissman
  • Patent number: 11254933
    Abstract: Methods, compositions, and kits are provided for CRISPR/Cas mediated transcriptional modulation.
    Type: Grant
    Filed: July 14, 2015
    Date of Patent: February 22, 2022
    Assignee: The Regents of the University of California
    Inventors: Luke A Gilbert, Max Horlbeck, Martin Kampmann, Lei S Qi, Jonathan S Weissman
  • Publication number: 20170219596
    Abstract: Methods, compositions, and kits are provided for imaging a polypeptide of interest. Methods, compositions, and kits are also provided for site-specific transcriptional regulation of one or more genetic elements.
    Type: Application
    Filed: July 14, 2015
    Publication date: August 3, 2017
    Inventors: Marvin E Tanenbaum, Luke A Gilbert, Lei S Qi, Jonathan S. Weissman, Ronald D Vale
  • Publication number: 20170204407
    Abstract: Methods, compositions, and kits are provided for CRISPR/Cas mediated transcriptional modulation.
    Type: Application
    Filed: July 14, 2015
    Publication date: July 20, 2017
    Inventors: Luke A GILBERT, Max HORLBECK, Martin KAMPMANN, Lei S QI, Jonathan S WEISSMAN